Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
World Journal of Urology|June 23, 2018
An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancerFrancesco Soria, Michael J Droller, Yair Lotan, et al.
European Urology Focus|June 14, 2020
Stratification of Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: Implications for Adjuvant TherapiesFrancesco Soria, David D'Andrea, Mohammad Abufaraj, et al.
World Journal of Urology|September 16, 2018
SIU-ICUD on bladder cancer: pathologyEva Compérat, Marek Babjuk, Ferran Algaba, et al.
Urologia Internationalis|September 5, 2015
Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder CancerAntonin Brisuda, Eva Pazourkova, Viktor Soukup, et al.
Advances in Experimental Medicine and Biology|October 19, 2016
Comparison of MicroRNA Content in Plasma and Urine Indicates the Existence of a Transrenal Passage of Selected MicroRNAsEva Pazourkova, Sarka Pospisilova, Iveta Svobodova, et al.
Urologic Oncology|February 19, 2017
Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancerMohammad Abufaraj, Shahrokh F Shariat, Andrea Haitel, et al.
Cancer Medicine|September 10, 2024
Clinical and molecular response to alpha1-oleate treatment in patients with bladder cancerFarhan Haq, Samudra Sabari, Jaromir Háček, et al.
European Urology|July 9, 2014
Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendationsJ Alfred Witjes, Marek Babjuk, Paolo Gontero, et al.
Urologic Oncology|July 14, 2020
Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: A systematic reviewKeiichiro Mori, Noriyoshi Miura, Marek Babjuk, et al.
Urologic Oncology|September 27, 2017
Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancerMalte Rieken, Shahrokh F Shariat, Luis Kluth, et al.
Pageof 8